UniProt ID | GNAI3_HUMAN | |
---|---|---|
UniProt AC | P08754 | |
Protein Name | Guanine nucleotide-binding protein G(k) subunit alpha {ECO:0000303|PubMed:2452165} | |
Gene Name | GNAI3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 354 | |
Subcellular Localization |
Cytoplasm . Cell membrane . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Membrane Lipid-anchor . Localizes in the centrosomes of interphase and mitotic cells. Detected at the cleavage furrow and/or the midbody. |
|
Protein Description | Heterotrimeric guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins. [PubMed: 8774883] | |
Protein Sequence | MGCTLSAEDKAAVERSKMIDRNLREDGEKAAKEVKLLLLGAGESGKSTIVKQMKIIHEDGYSEDECKQYKVVVYSNTIQSIIAIIRAMGRLKIDFGEAARADDARQLFVLAGSAEEGVMTPELAGVIKRLWRDGGVQACFSRSREYQLNDSASYYLNDLDRISQSNYIPTQQDVLRTRVKTTGIVETHFTFKDLYFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTETSIILFLNKKDLFEEKIKRSPLTICYPEYTGSNTYEEAAAYIQCQFEDLNRRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKECGLY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGCTLSAED ------CCCCCCHHH | 17.08 | 25255805 | |
3 | S-palmitoylation | -----MGCTLSAEDK -----CCCCCCHHHH | 3.14 | - | |
17 | Ubiquitination | KAAVERSKMIDRNLR HHHHHHHHHHCHHHH | 46.20 | 29967540 | |
29 | Ubiquitination | NLREDGEKAAKEVKL HHHHHHHHHHHHHHH | 60.21 | 21906983 | |
32 | Ubiquitination | EDGEKAAKEVKLLLL HHHHHHHHHHHHHEE | 68.82 | 22817900 | |
35 | Ubiquitination | EKAAKEVKLLLLGAG HHHHHHHHHHEECCC | 34.21 | 21906983 | |
35 | Ubiquitination | EKAAKEVKLLLLGAG HHHHHHHHHHEECCC | 34.21 | 21890473 | |
35 | Acetylation | EKAAKEVKLLLLGAG HHHHHHHHHHEECCC | 34.21 | 26051181 | |
44 | Phosphorylation | LLLGAGESGKSTIVK HEECCCCCCCCHHHH | 51.07 | 20873877 | |
46 | Ubiquitination | LGAGESGKSTIVKQM ECCCCCCCCHHHHEE | 54.42 | 23000965 | |
47 | Phosphorylation | GAGESGKSTIVKQMK CCCCCCCCHHHHEEE | 27.22 | 20873877 | |
48 | Phosphorylation | AGESGKSTIVKQMKI CCCCCCCHHHHEEEE | 33.02 | 29514088 | |
51 | Ubiquitination | SGKSTIVKQMKIIHE CCCCHHHHEEEEECC | 40.60 | 23000965 | |
54 | Acetylation | STIVKQMKIIHEDGY CHHHHEEEEECCCCC | 35.69 | 27452117 | |
54 | Ubiquitination | STIVKQMKIIHEDGY CHHHHEEEEECCCCC | 35.69 | 22817900 | |
61 | Phosphorylation | KIIHEDGYSEDECKQ EEECCCCCCHHHHCE | 22.62 | 21082442 | |
62 | Phosphorylation | IIHEDGYSEDECKQY EECCCCCCHHHHCEE | 44.06 | 28152594 | |
67 | Acetylation | GYSEDECKQYKVVVY CCCHHHHCEEEEEEE | 55.40 | 26051181 | |
67 | Ubiquitination | GYSEDECKQYKVVVY CCCHHHHCEEEEEEE | 55.40 | 29967540 | |
69 | Phosphorylation | SEDECKQYKVVVYSN CHHHHCEEEEEEECC | 7.40 | 25884760 | |
70 | Acetylation | EDECKQYKVVVYSNT HHHHCEEEEEEECCH | 26.51 | 7367651 | |
75 | O-linked_Glycosylation | QYKVVVYSNTIQSII EEEEEEECCHHHHHH | 18.85 | 28411811 | |
77 | O-linked_Glycosylation | KVVVYSNTIQSIIAI EEEEECCHHHHHHHH | 17.91 | 28411811 | |
80 | O-linked_Glycosylation | VYSNTIQSIIAIIRA EECCHHHHHHHHHHH | 16.47 | 28411811 | |
92 | Ubiquitination | IRAMGRLKIDFGEAA HHHHCCCCCCHHHHH | 38.58 | 23000965 | |
92 | Ubiquitination | IRAMGRLKIDFGEAA HHHHCCCCCCHHHHH | 38.58 | 21890473 | |
92 | Acetylation | IRAMGRLKIDFGEAA HHHHCCCCCCHHHHH | 38.58 | 26051181 | |
92 | Sumoylation | IRAMGRLKIDFGEAA HHHHCCCCCCHHHHH | 38.58 | - | |
128 | Ubiquitination | PELAGVIKRLWRDGG HHHHHHHHHHHHCCC | 38.75 | 21906983 | |
144 | Methylation | QACFSRSREYQLNDS EEEEECCCCEECCCC | 45.60 | - | |
161 | Methylation | YYLNDLDRISQSNYI HHHCCHHHHHHCCCC | 37.44 | - | |
163 | Phosphorylation | LNDLDRISQSNYIPT HCCHHHHHHCCCCCC | 28.57 | 25850435 | |
165 | Phosphorylation | DLDRISQSNYIPTQQ CHHHHHHCCCCCCHH | 25.47 | 28152594 | |
167 | Phosphorylation | DRISQSNYIPTQQDV HHHHHCCCCCCHHHH | 17.33 | 28152594 | |
178 | ADP-ribosylation | QQDVLRTRVKTTGIV HHHHHHHHHCCCCEE | 22.85 | - | |
178 | ADP-ribosylation | QQDVLRTRVKTTGIV HHHHHHHHHCCCCEE | 22.85 | - | |
180 | Ubiquitination | DVLRTRVKTTGIVET HHHHHHHCCCCEEEE | 36.76 | 30230243 | |
192 | Ubiquitination | VETHFTFKDLYFKMF EEEEEEEHHHEEEEE | 43.71 | 21890473 | |
192 | Ubiquitination | VETHFTFKDLYFKMF EEEEEEEHHHEEEEE | 43.71 | 23000965 | |
197 | Acetylation | TFKDLYFKMFDVGGQ EEHHHEEEEEECCCC | 25.71 | 27452117 | |
197 | Ubiquitination | TFKDLYFKMFDVGGQ EEHHHEEEEEECCCC | 25.71 | 23000965 | |
204 | Deamidated glutamine | KMFDVGGQRSERKKW EEEECCCCCCCHHHH | 39.54 | - | |
204 | Deamidation | KMFDVGGQRSERKKW EEEECCCCCCCHHHH | 39.54 | 24141704 | |
206 | Phosphorylation | FDVGGQRSERKKWIH EECCCCCCCHHHHHH | 33.59 | 23401153 | |
248 | Ubiquitination | NRMHESMKLFDSICN HHHHHHHHHHHHHHC | 56.11 | 21890473 | |
248 | Ubiquitination | NRMHESMKLFDSICN HHHHHHHHHHHHHHC | 56.11 | 23000965 | |
252 | Phosphorylation | ESMKLFDSICNNKWF HHHHHHHHHHCCCCC | 23.00 | 25159151 | |
257 | Ubiquitination | FDSICNNKWFTETSI HHHHHCCCCCCHHEE | 29.68 | 23503661 | |
271 | Ubiquitination | IILFLNKKDLFEEKI EEEEECHHHHHHHHH | 59.60 | - | |
277 | Ubiquitination | KKDLFEEKIKRSPLT HHHHHHHHHHCCCCE | 46.45 | 21890473 | |
277 | Acetylation | KKDLFEEKIKRSPLT HHHHHHHHHHCCCCE | 46.45 | 27452117 | |
317 | Ubiquitination | LNRRKDTKEIYTHFT HCCCCCCCHHCCEEE | 52.85 | 30230243 | |
317 | Acetylation | LNRRKDTKEIYTHFT HCCCCCCCHHCCEEE | 52.85 | 26051181 | |
320 | Phosphorylation | RKDTKEIYTHFTCAT CCCCCHHCCEEEECC | 8.68 | 28152594 | |
330 | Ubiquitination | FTCATDTKNVQFVFD EEECCCCCCCEEEHH | 58.91 | 33845483 | |
345 | Ubiquitination | AVTDVIIKNNLKECG HHHHHHHHCCCHHCC | 28.76 | 32015554 | |
349 | Ubiquitination | VIIKNNLKECGLY-- HHHHCCCHHCCCC-- | 53.75 | 27667366 | |
351 | ADP-ribosylation | IKNNLKECGLY---- HHCCCHHCCCC---- | 4.32 | - | |
351 | ADP-ribosylation | IKNNLKECGLY---- HHCCCHHCCCC---- | 4.32 | - | |
354 | Phosphorylation | NLKECGLY------- CCHHCCCC------- | 11.20 | 25884760 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
204 | Q | Amidation |
| 24141704 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GNAI3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
602483 | Auriculocondylar syndrome 1 (ARCND1) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-354, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-69, AND MASSSPECTROMETRY. |